[Source Genetic Engineering News] – The Ben and Catherine Ivy Foundation (Ivy Foundation) has awarded $3 million to the Translational Genomics Research Institute (TGen) to conduct gene-based studies on brain tumors. The grant was obtained through the Ivy Genomics-Based Medicine (G.B.M.) Project, a collaboration between nine U.S. institutions.
Joining TGen on this project are Ohio State University, The University of Texas M. D. Anderson Cancer Center, University of Alabama at Birmingham, University of California, San Francisco, Henry Ford Hospital, Mayo Clinic, Case Western Reserve University School of Medicine, and Van Andel Research Institute.
The goal of the consortium is to identify gene signatures that help predict the most effective treatment option for each patient. Research will categorize tumors by molecular profiling and test each tumor against various treatments to match differences in response with the profiles.